In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 16 | Yes |
Popular Name: 4-(1,3-benzothiazol-2-yl)aniline 4-(1,3-benzothiazol-2-yl)aniline
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 6278-73-5
4-(1,3-Benzothiazol-2-yl)phenylamine
4-(2-Benzothiazolyl)aniline, 98%
4-(Benzo[d]thiazol-2-yl)aniline
4-Benzothiazol-2-yl-phenylamine
benzenamine, 4-(2-benzothiazolyl)-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.37 | 5.65 | -8.79 | 2 | 2 | 0 | 39 | 226.304 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 149 - 151 | Enamine Building Blocks |
MP | 149...151 | Enamine Building Blocks |
MP | 150-153° | Matrix Scientific |
Melting_Point | 152-154? | Alfa-Aesar |
Melting_Point | 152-154° | Alfa-Aesar |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 97% | Fluorochem |
Warnings | IRRITANT | Matrix Scientific |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
A4-2-E | Beta Amyloid A4 Protein (cluster #2 Of 5), Eukaryotic | Eukaryotes | 37 | 0.65 | Binding ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 1 | 0.79 | Functional ≤ 10μM |
Z80244-2-O | MDA-MB-468 (Breast Adenocarcinoma) (cluster #2 Of 7), Other | Other | 2 | 0.76 | Functional ≤ 10μM |
Z80475-2-O | SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other | Other | 8 | 0.71 | Functional ≤ 10μM |
Z80608-4-O | ZR-75-1 (Breast Carcinoma Cells) (cluster #4 Of 4), Other | Other | 28 | 0.66 | Functional ≤ 10μM |
Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 17 | 0.68 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
A4_HUMAN | P05067 | Beta Amyloid A4 Protein, Human | 37 | 0.65 | Binding ≤ 1μM |
A4_HUMAN | P05067 | Beta Amyloid A4 Protein, Human | 37 | 0.65 | Binding ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 0.1 | 0.88 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 17 | 0.68 | Functional ≤ 10μM |
Z80244 | Z80244 | MDA-MB-468 (Breast Adenocarcinoma) | 1 | 0.79 | Functional ≤ 10μM |
Z80475 | Z80475 | SK-BR-3 (Breast Adenocarcinoma) | 8.1 | 0.71 | Functional ≤ 10μM |
Z80608 | Z80608 | ZR-75-1 (Breast Carcinoma Cells) | 28 | 0.66 | Functional ≤ 10μM |
Description | Species |
---|---|
Advanced glycosylation endproduct receptor signaling | |
Amyloids | |
DEx/H-box helicases activate type I IFN and inflammatory cytokines production | |
ECM proteoglycans | |
Formyl peptide receptors bind formyl peptides and many other ligands | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
Platelet degranulation | |
RIP-mediated NFkB activation via ZBP1 | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
The NLRP3 inflammasome | |
TRAF6 mediated NF-kB activation |
No pre-computed analogs available. Try a structural similarity search.